- Home
- HQL vs AVNS Comparison
HQL vs AVNS Comparison
Compare HQL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQL | AVNS |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.5M | 521.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | HQL | AVNS |
|---|---|---|
| Price | $16.23 | $13.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 109.0K | ★ 583.1K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $701,200,000.00 |
| Revenue This Year | N/A | $3.28 |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | $20.61 | ★ N/A |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $10.55 | $9.30 |
| 52 Week High | $17.80 | $15.68 |
Technical Indicators
Market Signals| Indicator | HQL | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 40.25 |
| Support Level | $15.66 | $12.75 |
| Resistance Level | $17.51 | $13.11 |
| Average True Range (ATR) | 0.31 | 0.51 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 42.46 | 22.70 |
Price Performance
Historical ComparisonAbout HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.